| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | O05EC62663 |
| InChI Key | PHYFQTYBJUILEZ-IUPFWZBJSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C57H104O6 |
| Molecular Weight | 885.45 |
| AlogP | 18.1 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 50.0 |
| Polar Surface Area | 78.9 |
| Molecular species | None |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 63.0 |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Adrenoleukodystrophy | Phase 2/Phase 3 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 122-32-7 |
| ChEBI | 53753 |
| ChEMBL | CHEMBL4297656 |
| DrugBank | DB13038 |
| EPA CompTox | DTXSID3026988 |
| FDA SRS | O05EC62663 |
| Human Metabolome Database | HMDB0005453 |
| PubChem | 5497163 |
| SureChEMBL | SCHEMBL23730 |
| ZINC | ZINC000085545180 |